Sign in with Google
|
USD 82.81
Price
-0.35
(-0.42%)
Day Change
|
|
|---|
GILD, the overall quality is good (Quality = 77) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROE is decreasing significantly
Net profit margin is relatively low.
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
| Quality Factors |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.03 From 30 days period |
| Social Score | 2 |
| Magic Formula Rank by ROA |
1817
|
| Magic Formula Rank by ROE |
1817
|
| Magic Formula Rank by ROIC |
1994
|
| Price | 82.81 |
| PBV / Sector |
5.64 / 17.03
|
| Earning Per Share | 0.82 |
| PE / Sector |
101.41 / 42.76
|
| PEG or PE/Growth / Sector |
0.49 / 1.58
GOOD
|
| Average 1M Daily Value |
431.39 M
GREAT
|
| Average 1W Daily Value |
584.20 M
|
| Timing Factors |
|
85% |
| Financial Health |
|
52% |
| Ability to Make Profit |
|
70% |
| Return to Investors |
|
33% |
| Registration Details |
| Analyze Date | 2024-09-14 18:49:49 |
| Symbol | GILD |
| Name | GILEAD SCIENCES INC |
| Sector | Healthcare >> Drug Manufacturers - General |
| Market | NASDAQ |
| Listed Shares | 1,244.99 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 103,533.37 / 223,367.13 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
AZN 
JNJ 
NVS 
